[1]
YALÇIN, K. et al. 2004. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels. Turkish Journal of Gastroenterology. 15, 1 (Jan. 2004), 14–20.